Jefferies Group's BSX Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 302,499 shares of Boston Scientific Corporation (BSX) worth $29.53 M, representing 0.14% of the portfolio. First purchased in 2018-Q2, this long-term strategic position has been held for 30 quarters.
Based on 13F filings, Jefferies Group has maintained a strategic position in BSX, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2024, adding 647,731 shares. Largest reduction occurred in Q4 2024, reducing 321,497 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's Boston Scientific Corporation (BSX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Boston Scientific Corporation (BSX) Trades by Jefferies Group
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2018 | +25,000 | New Buy | 25,000 | $32.68 |
| Q3 2018 | -25,000 | Sold Out | 25,000 | $0.00 |
| Q4 2022 | +1,034 | New Buy | 1,034 | $46.27 |
| Q1 2023 | +183,304 | Add 17727.66% | 184,338 | $50.03 |
| Q2 2023 | +206,696 | Add 112.13% | 391,034 | $54.09 |
| Q3 2023 | -72,493 | Reduce 18.54% | 318,541 | $52.80 |
| Q4 2023 | +146,602 | Add 46.02% | 465,143 | $57.81 |
| Q1 2024 | -252,494 | Reduce 54.28% | 212,649 | $68.49 |
| Q2 2024 | +647,731 | Add 304.60% | 860,380 | $77.01 |
| Q3 2024 | -201,574 | Reduce 23.43% | 658,806 | $83.80 |
| Q4 2024 | -321,497 | Reduce 48.80% | 337,309 | $89.32 |
| Q1 2025 | -248,431 | Reduce 73.65% | 88,878 | $100.88 |
| Q2 2025 | +168,761 | Add 189.88% | 257,639 | $107.41 |
| Q3 2025 | +44,860 | Add 17.41% | 302,499 | $97.63 |
Jefferies Group's Boston Scientific Corporation Investment FAQs
Jefferies Group first purchased Boston Scientific Corporation (BSX) in Q2 2018, acquiring 25,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held Boston Scientific Corporation (BSX) for 30 quarters since Q2 2018. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group's largest addition to Boston Scientific Corporation (BSX) was in Q2 2024, adding 860,380 shares worth $66.26 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Jefferies Group's firm, Jefferies Financial Group Inc., owns 302,499 shares of Boston Scientific Corporation (BSX), valued at approximately $29.53 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Boston Scientific Corporation (BSX) represents approximately 0.14% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group's peak holding in Boston Scientific Corporation (BSX) was 860,380 shares, as reported at the end of Q2 2024. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.